Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Noninvasive tests boost risk stratification in obese compensated ACLD

Key clinical point: Noninvasive testing may improve risk stratification in compensated advanced chronic liver disease

Major finding: Portal hypertension had an area under the curve of 0.829 (P less than .001) vs. 0.803 for liver stiffness measurement (P < .001).

Study details: Retrospective study of 272 consecutive patients with chronic liver disease who had liver stiffness measurement by transient elastography with XL probe from 2015 to January 2018.

Disclosures: The study received funding from the Swiss government. Dr. Mendoza and coauthors have no financial relationships to disclose.


Mendoza Y et al. Clin Gastroenterol Hepatol. 2020. doi: 10.1016/j.cgh.2020.04.018.